{
  "id": "b000ccbf79832aa5",
  "title": "GLP - 1 RA Use Linked to 42 % Hepatocellular Carcinoma Risk Reduction in T2DM",
  "description": "20251215T194500Z",
  "content": "",
  "source": "hcplive.com",
  "source_url": "https://www.hcplive.com/view/glp-1-ra-use-linked-42-hepatocellular-carcinoma-risk-reduction-t2dm",
  "published_at": "20251215T194500Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.hcplive.com/view/glp-1-ra-use-linked-42-hepatocellular-carcinoma-risk-reduction-t2dm",
    "url_mobile": "",
    "title": "GLP - 1 RA Use Linked to 42 % Hepatocellular Carcinoma Risk Reduction in T2DM",
    "seendate": "20251215T194500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/hcplive/039b780a324dfaa9014c4872c39e5651f9e0fa78-1200x630.png",
    "domain": "hcplive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}